Virtual Congressional Briefing: Potential of Psychedelics in the Treatment of Psychiatric Diseases: A Long, Strange Trip Toward Future Therapy
October 11, 2024 | Uncategorized
On September 21, 2022 at 2 PM EST, you’re invited to join the American Brain Coalition and American College of Neuropsychopharmacology, in cooperation with Congressman Earl Blumenauer (OR), for a virtual Congressional Briefing examining the role psychedelic drugs are playing in addressing psychiatric illness, including substance use disorders. We will also discuss barriers to research with psychedelic compounds. Click here for registration information.
Opening Remarks
Representative Earl Blumenauer (D-OR)
Co-Chair, Congressional Neuroscience Caucus
Speakers
Nora D. Volkow, MD
Director
National Institute on Drug Abuse (NIDA)
National Institutes of Health
Marcus Capone
Former Navy SEAL and Founder and Chair of VETS Inc.
Operating Partner at Red Cell Partners
Founder of Tåra – Expanding access to Psychedelic Therapy
Rachel Yehuda, PhD
Professor of Psychiatry and Neuroscience of Trauma, Icahn School of Medicine at Mount Sinai
Director of Mental Health, James J. Peters Veterans Affairs Medical Center